|
Status |
Public on Dec 29, 2021 |
Title |
RNA-Seq analysis (long-reads) of human parental M238P and BRAF inhibitors-resistant M238R melanoma cells |
Organism |
Homo sapiens |
Experiment type |
Non-coding RNA profiling by high throughput sequencing
|
Summary |
M238P BRAFV600E mutant melanoma cells sensitive to the BRAF inhibitor Vemurafenib (PLX4032) and the corresponding resistant M238R cell line were cultured in standard conditions. RNA samples were then harvested and sequenced with the Nanopore long-reads protocol.
|
|
|
Overall design |
2 samples: M238P versus M238R
|
|
|
Contributor(s) |
Serena D, Truchi M, Mari B, Kevin L |
Citation(s) |
35156321 |
|
Submission date |
Apr 12, 2021 |
Last update date |
Mar 15, 2022 |
Contact name |
Kevin Lebrigand |
Organization name |
IPMC/CNRS
|
Lab |
Functional Genomics Platform of Nice-Sophia-Antipolis, France.
|
Street address |
660 route des lucioles
|
City |
Valbonne - Sophia-Antipolis |
ZIP/Postal code |
06560 |
Country |
France |
|
|
Platforms (1) |
|
Samples (2) |
|
This SubSeries is part of SuperSeries: |
GSE171883 |
Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma |
|
Relations |
BioProject |
PRJNA721322 |
SRA |
SRP314440 |